The novel microvascular resistance reserve (MRR) proved to be an independent predictor of the risk of the composite of all-cause mortality or heart failure hospitalization when measured directly after primary percutaneous coronary intervention (PCI) in patients who experienced ST-elevation myocardial infarction (STEMI), according to a post hoc analysis of pooled patient data.